259
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort

, , , , , , , , , , , , & show all
Pages 260-268 | Received 16 Sep 2023, Accepted 28 Oct 2023, Published online: 06 Nov 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Antonio Tursi, Giammarco Mocci, Franco Scaldaferri, Daniele Napolitano, Rossella Maresca, Daniela Pugliese, Gianluca Semprucci, Edoardo Savarino, Antonio Cuomo, Laura Donnarumma, Giorgia Bodini, Andrea Pasta, Giovanni Maconi, Giovanni Cataletti, Giuseppe Pranzo, Stefano Rodinò, Ladislava Sebkova, Francesco Costa, Antonio Ferronato, Federica Gaiani, Manuela Marzo, Ileana Luppino, Giulia Fabiano, Pietro Paese, Walter Elisei, Rita Monterubbianesi, Roberto Faggiani, Laurino Grossi, Mariaelena Serio, Antonella Scarcelli, Roberto Lorenzetti, Leonardo Allegretta, Stefania Chiri, Giuseppina Grasso, Elisabetta Antonelli, Gabrio Bassotti, Rocco Spagnuolo, Francesco Luzza, Libera Fanigliulo, Giulia Rocco, Carlotta Sacchi, Costantino Zampaletta, Chiara Rocchi, Laura Bolognini, Emanuele Bendia, Maria Antonia Bianco, Pietro Capone, Costantino Meucci, Raffaele Colucci, Paolo Tonti, Viviana Neve, Nicola Della Valle, Carla Felice, Roberta Pica, Andrea Cocco, Giacomo Forti, Francesca Maria Onidi, Paolo Usai Satta, Davide Checchin, Antonietta Gerarda Gravina, Raffaele Pellegrino, Marcello Picchio & Alfredo Papa. (2024) Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study. Expert Opinion on Biological Therapy 24:1-2, pages 101-109.
Read now

Articles from other publishers (1)

Giammarco Mocci, Antonio Tursi, Francesca Maria Onidi, Paolo Usai-Satta, Giovanni Mario Pes & Maria Pina Dore. (2024) Ustekinumab in the Treatment of Inflammatory Bowel Diseases: Evolving Paradigms. Journal of Clinical Medicine 13:5, pages 1519.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.